Natural history of hepatitis C. (Q33809416)

29 July 2017

1 reference

title

Natural history of hepatitis C. (English)

1 reference

29 July 2017

Alberti A

1

1 reference

29 July 2017

Chemello L

series ordinal

2

1 reference

29 July 2017

Benvegnù L

series ordinal

3

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

published in

Journal of Hepatology

1 reference

29 July 2017

volume

31 Suppl 1

1 reference

29 July 2017

page(s)

17-24

1 reference

Lymphocyte Reactivity to Hepatitis C Virus (HCV) Antigens Shows Evidence for Exposure to HCV in HCV‐Seronegative Spouses of HCV‐Infected Patients

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Hepatitis C virus viremia following clinical resolution of acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Histological evolution of chronic hepatitis C. Factors related to progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Long-term follow-up of chronic hepatitis non-A, non-B - with special reference to hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

The long-term pathological evolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Prognosis of chronic hepatitis C: results of a large, prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Cost-Effectiveness of 6 and 12 Months of Interferon-α Therapy for Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Estimates of the Cost-Effectiveness of a Single Course of Interferon-α2b in Patients with Histologically Mild Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Histopathology of chronic hepatitis C in relation to epidemiological factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

MHC class II genes influence the susceptibility to chronic active hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Management of chronic hepatitis C in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

Modeling the hepatitis C virus epidemic in France

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980369-9

7 January 2021

10.1016/S0168-8278(99)80369-9

Identifiers

DOI

1 reference

29 July 2017

1 reference